ГОСТ 32519-2013
Mice. Neurobehav. Toxicol., 1, 233-236. Draft consultant’s proposal. V. 8.
OECD TG 452 November, 2008, 14
[31] Crofton K.M., Howard J.L., Moser V.C., Gill M.W., Reiter L.W., Tilson
H.A., MacPhail R.C. (1991). Interlaboratory Comparison of Motor Activity
Experiments: Implication for Neurotoxicological Assessments. Neurotoxicol.
Teratol., 13, 599-609.
[32] Weingand K, Brown G, Hall R et al. (1996). Harmonisation of Animal
Clinical Pathology Testing in Toxicity and Safety Studies. Fundam. & Appl.
Toxicol., 29: 198-201.
[33] EMEA (draft) document ‘Non-clinical guideline on drug-induced
hepatotoxicity’ (Doc. Ref. EMEA/CHMP/SWP/a50115/2006)
[34] Crissman JW, Goodman DG, Hildebrandt PK et al. (2004). Best
Practices Guideline: Toxicological Histopathology. Toxicologic Pathology
32, 126-131.
28